COO

The Cooper Companies, Inc.

Healthcare · $10.5B market cap

Share price

$56.91

close of Oct 3, 2026

Fair value

$64.50

Sticker Price

Payback Price

$25.80

buy price

Undervalued

COO is Undervalued: at $56.91 it trades 12% below its fair value of $64.50. Its buy price (Payback Price) is $25.80, 55% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Owner Earnings. Earnings grow slowly (under 7% a year), but cash flow is steady, so we value it on its cash flow instead of its earnings.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth4.6% a year✗

Equity per share growth8.7% a year✗

Sales growth8.6% a year✗

Free cash flow growth5.5% a year✗

Return on invested capital3.9%✗

Follow COO

Get notified when it reaches its buy price of $25.80. Free.

Create a free account

Superinvestors

2 of the investors we track hold COO. In Q2 2026, 1 opened a position. Who we track

Bill Nygren

Oakmark Funds · as of Q2 2026

$55.0M

766,520 shares

Torray Funds

Torray Funds · as of Q2 2026

$1.7M

23,286 shares

Moves in Q2 2026

New position: Bill Nygren

Insider activity

Since Jul 1, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

Keel Paul A

director · 2026-07-01

Award

2,814 shares

About The Cooper Companies, Inc.

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for…

Medical - Instruments & Supplies